A detailed, data-backed consultation designed to assess biotech assets through clinical, regulatory, and market lenses—ideal for investors preparing for key decisions.
🧬 Tier 2: Due Diligence Deep Dive
750,00 €
€750 / hour (Minimum 3 hours recommended)
Detailed clinical, regulatory & market analysis.
Best for:
Institutional investors preparing for a funding round, catalyst trade, or partnership evaluation.
What’s Included:
-
Thorough review of trials, endpoints, and regulatory path
-
MoA differentiation & competitor risk mapping
-
Sentiment from top-tier thought leaders & investigators
-
Timeline of catalysts (12–18 months outlook)
-
2–3 page written briefing document
Next Step:
Once payment is complete, we’ll reach out directly to align on your target asset, timeframe, and key questions.
Reviews
There are no reviews yet.